SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased social media attention as community members debate its potential for a turnaround, bolstered by recent discussions regarding its post-quantum cryptography features and institutional adoption. While some investors are expressing frustration over performance, others are actively accumulating tokens, citing its technical infrastructure as a foundational advantage for long-term growth.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending as community members rally behind potential supply-reduction catalysts, such as future token burns and proposed network upgrades, leading to widespread speculation about a significant price recovery. While some investors view these moves as a long-term play backed by the community and ecosystem development, others remain skeptical, warning of high volatility and the potential for a pump-and-dump cycle.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

The SPERMWHALE crypto community is actively trading on high volatility and speculative momentum, with many users focused on social media sentiment and the potential for a rebound to previous highs. The project remains a focal point for discussion among meme coin traders despite ongoing debates regarding its long-term viability and the presence of competing new token launches.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following the announcement of a preliminary Phase 3 trial design for its CAD-1005 program for Heparin-Induced Thrombocytopenia, marking a key milestone after end-of-Phase 2 FDA meetings. While supporters point to the potential of its cardiovascular pipeline and Orphan Drug designations as catalysts, community sentiment remains deeply divided as critics raise concerns regarding consistent bot-driven spam and the company's historical reliance on dilutive capital raises.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple's XRP is facing intense community debate and stagnation as investors weigh the potential impacts of the Clarity Act against ongoing frustration over price movement. While some participants are positioning for a breakout tied to institutional adoption and regulatory milestones, others are expressing significant fatigue, labeling the asset stagnant and comparing its recent performance to penny stocks.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos is generating intense community discussion as users debate its long-term value, with many focusing on the proposed tokenomics overhaul intended to shift the network toward a more sustainable, revenue-based economic model. While some traders view the current price action as an accumulation opportunity driven by its robust ecosystem and staking rewards, others express frustration over its underperformance compared to other major crypto assets and are actively debating its future viability.

Daddy Darth Vader

Community members are rallying behind $DARTH following the departure of the developer, framing the project as a community-driven "Daddy" meme coin currently engaged in a rivalry with other market participants. Discussion is heavily focused on potential price catalysts leading up to May 4th, with participants actively debating the transition to a decentralized model and speculating on future liquidity and growth.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Celcuity Inc. is trending due to positive Phase 3 VIKTORIA-1 trial data, where the drug gedatolisib demonstrated clinically significant improvement in progression-free survival for HR+/HER2- breast cancer patients. The community is actively discussing the stock's potential for accelerated FDA approval, the implications of its upcoming PDUFA date, and speculation regarding potential M&A activity given the company's emerging status in oncology.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending as the community rallies around its unique 'brandcoin' model, which pairs aggressive marketing with a diverse range of real-world initiatives like energy drinks, apparel, and athletic sponsorships. Investors are actively discussing the project's long-term potential, frequently citing its high level of social engagement and consistent, organic growth as reasons for their bullish conviction.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is seeing significant community interest driven by upcoming CHOPIN trial data, with investors weighing the stock's long-term commercial potential against recent volatility and revenue guidance adjustments. While many focus on the product's long-term platform value, discussion remains divided between those interpreting recent price action as a strategic accumulation zone and those concerned about the impact of institutional short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Water Stocks To Add to Your Watchlist - May 2nd

CocaCola, IDEXX Laboratories, Ecolab, American Water Works, NuScale Power, Waters, and Xylem are the seven Water stocks to watch today, according to MarketBeat's stock screener tool. Water stocks are...

Water Stocks To Follow Now - May 1st

CocaCola, NuScale Power, IDEXX Laboratories, Waters, and Ecolab are the five Water stocks to watch today, according to MarketBeat's stock screener tool. Water stocks are shares of companies whose...

Here's How IDEXX Laboratories Is Placed Ahead of Q1 Earnings

IDXX heads into Q1 earnings with strong growth forecasts, steady estimate beats, and momentum in diagnostics and recurring revenue streams.

Oppenheimer Asset Management Inc. Raises Position in IDEXX Laboratories, Inc. $IDXX

Oppenheimer Asset Management Inc. increased its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 13.0% during the fourth quarter, according to the company in its most recent 13F...

What Analyst Projections for Key Metrics Reveal About Idexx (IDXX) Q1 Earnings

Beyond analysts' top-and-bottom-line estimates for Idexx (IDXX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.

IDEXX Laboratories, Inc. $IDXX Stake Boosted by Wealthfront Advisers LLC

Wealthfront Advisers LLC increased its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 78.5% during the fourth quarter, according to its most recent 13F filing with the Securities...

UBS Group AG Has $192.78 Million Holdings in IDEXX Laboratories, Inc. $IDXX

UBS Group AG lessened its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 18.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and...

Sanctuary Advisors LLC Purchases 7,186 Shares of IDEXX Laboratories, Inc. $IDXX

Sanctuary Advisors LLC increased its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 129.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,736 shares of the company's stock after acquiring a...

Comerica Bank Sells 9,639 Shares of IDEXX Laboratories, Inc. $IDXX

Comerica Bank lessened its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 35.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange...

IDEXX Laboratories (IDXX) Projected to Post Earnings on Tuesday

IDEXX Laboratories (NASDAQ:IDXX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.

Current Price	$567.46
Prev Close	$560.80
Open	$564.70
Dividend Yield	0.00%
50-Day Moving Average	$589.50
Beta	1.08
Avg. Volume	537,225.22
PE Ratio	43.38

52-Week High	$769.98
52-Week Low	$465.00
Market Capitalization	$45.07B
EPS (Annual)	$13.08
Price to Book	28.18
Revenue Per Employee	$391,245.64

IDXX
Idexx Laboratories Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IDXX News

IDXXIdexx Laboratories Inc